Skip to main content
. 2022 Apr 15;28(9):1263–1271. doi: 10.1016/j.cmi.2022.04.004

Fig. 2.

Fig. 2

Solicited local and systemic AEs. The percentage of participants in each group (SpikoGen®, Placebo) with Adverse Events (AEs) according to the maximum Food and Drug Administration (FDA) toxicity grading scale during the 7 days after each vaccination is plotted for solicited local (Panel A) and systemic (Panel B) adverse events. There was no grade 4 (life-threatening) event.